Interview with Steve Kerridge, Executive Chairman, Apodi
You joined Apodi in 2008, after a hiatus from the industry following the sale of your previous company, In2Focus,…
Apodi
Last updated: 13.02.2014
Address: One St Peters Road, Maidenhead, Berkshire SL6 7QU, United Kingdom
Tel: 01628 500890
Company description
Established in 2008 by a group of highly experienced outsourcing business specialists, Apodi provides comprehensive outsourcing solutions to the pharmaceutical and healthcare businesses and organisations.
Apodi recognizes that the business environment for these industry sectors is changing, and that there is a need for highly professional, tailored outsourcing services offering a rapid, effective response and delivering the best ROI.
Through commercial insight, market intelligence and highly motivated people, Apodi exists to help clients achieve improved outcomes and performance.
Products and services
HR Services
Resourcing Services
Healthcare Services
Teams Services
Commercialization Services
Interviews
Related
Kathy Pritchard-Jones – President, International Society of Paediatric…
Kathy Pritchard-Jones, Professor of Paediatric Oncology at University College London (UCL) and President of the…
Zack Pemberton-Whiteley – CEO, Leukaemia Care
Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient…
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
M&A / Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for Cannabinoid Research
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
UK / New Post-Brexit Regulatory Alliance with Australia, Canada, Singapore & Switzerland
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
UK-Japan FTA / Banishing UK Pharma's Brexit Blues
The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…
UK / MSD to Build USD 1.3 Billion London Research Hub in Boon for Post-Brexit Britain
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central…
Opinion / 3 Ways the UK’s Pharma Sector is Driving Innovation
Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical…
News Roundup / UK Pharma May 2020
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
Coronavirus / GSK & Sanofi’s Unprecedented COVID-19 Vaccine Collaboration
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
The UK / The G7’s Hottest Life Science Investment Destination?
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is…
